Cargando…
Selective Killing of Tumors Deficient in Methylthioadenosine Phosphorylase: A Novel Strategy
BACKGROUND: The gene for methylthioadenosine phosphorylase (MTAP) lies on 9p21, close to the gene CDKN2A that encodes the tumor suppressor proteins p16 and p14ARF. MTAP and CDKN2A are homozygously co-deleted, with a frequency of 35 to 70%, in lung and pancreatic cancer, glioblastoma, osteosarcoma, s...
Autores principales: | Lubin, Martin, Lubin, Adam |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2684647/ https://www.ncbi.nlm.nih.gov/pubmed/19478948 http://dx.doi.org/10.1371/journal.pone.0005735 |
Ejemplares similares
-
Correction: Selective Killing of Tumors Deficient in Methylthioadenosine Phosphorylase: A Novel Strategy
por: Lubin, Martin, et al.
Publicado: (2010) -
Methylthioadenosine phosphorylase deficiency in tumors: A compelling therapeutic target
por: Fan, Na, et al.
Publicado: (2023) -
Characterization and Prognostic Significance of Methylthioadenosine Phosphorylase Deficiency in Nasopharyngeal Carcinoma
por: He, Hong-Lin, et al.
Publicado: (2015) -
The essential role of methylthioadenosine phosphorylase in prostate cancer
por: Bistulfi, Gaia, et al.
Publicado: (2016) -
Expression and Function of Methylthioadenosine Phosphorylase in Chronic Liver Disease
por: Czech, Barbara, et al.
Publicado: (2013)